简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Alvotech GAAP每股收益为-0.61美元,收入为2.36亿美元

2024-08-16 04:28

  • Alvotech press release (NASDAQ:ALVO): 1H GAAP EPS of -$0.61.
  • Revenue of $236M (+938.7% Y/Y).
  • Adjusted EBITDA in the first six months was $64 million, compared to negative ($147) million for the same period last year, with Q2 adjusted EBITDA contributing $102 million
  • Achieved numerous development and performance milestones including the recent filing acceptance of EU marketing application for AVT06, biosimilar candidate to Eylea® (aflibercept).

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。